Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.70 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | ARG2 | P78540 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 4/20 | 0.44 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.43 |
| ▸ | TOP1 | P11387 | 1/20 | 0.42 |
| ▸ | AGXT | P21549 | 1/20 | 0.42 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | NOS3 | P29474 | 1/20 | 0.38 |
| ▸ | NOS1 | P29475 | 1/20 | 0.38 |
| ▸ | NOS2 | P35228 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12655770 | 1.00 | MAOB (0.70) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL6014431 | 1.00 | MAOB (0.70) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL5630066 | 0.86 | MAOB (0.52) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL5630072 | 0.86 | MAOB (0.52) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL9285426 | 0.86 | MAOB (0.48) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL6662237 | 0.83 | MAOB (0.61) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL155054 | 0.83 | MAOB (1.00) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL155055 | 0.83 | MAOB (1.00) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL1524697 | 0.83 | MAOB (1.00) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL9288720 | 0.82 | MAOB (0.46) | MAOBCA1CA2ARG2IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 760 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113549009-B | Industrial synthesis method of 2,3-dichloropyridine | 河北野田农用化学有限公司 | 2022-07-26 | — | — | CN | claimed |
| CN-113549009-A | Industrial synthesis method of 2,3-dichloropyridine | 河北野田农用化学有限公司 | 2021-10-26 | — | — | CN | claimed |
| WO-2020029846-A1 | RAPID SYNTHESIS METHOD FOR BIOMASS-BASED AMINE COMPOUND | 南京农业大学 | 2020-02-13 | — | — | WO | claimed |
| CN-103596669-B | Hydridization encapsulating material manufacturing method | 韩国电气研究院 | 2019-04-09 | — | — | CN | claimed |
| EP-1788048-B1 | HIGH-SOLID ANTICORROSIVE COATING COMPOSITION, HIGH-SOLID RAPIDLY-CURABLE ANTICORROSIVE COATING COMPOSITION, METHOD OF COATING SHIP OR THE LIKE, HIGH-SOLID ANTICORROSIVE FILM AND RAPIDLY CURED HIGH-SOLID ANTICORROSIVE FILM OBTAINED, AND COATED SHIP AND UNDERWATER STRUCTURE COATED WITH THESE COATING FILMS | CHUGOKU MARINE PAINTS (JP) | 2010-10-06 | — | — | EP | claimed |
| US-20090226729-A1 | HIGH-SOLID ANTICORROSIVE COATING COMPOSITION, HIGH-SOLID RAPIDLY-CURABLE ANTICORROSIVE COATING COMPOSITION, METHOD OF COATING SHIP OR THE LIKE, HIGH-SOLID ANTICORROSIVE FILM AND RAPIDLY CURED HIGH- ANTICORROSIVE FILM OBTAINED, AND COATED SHIP AND UNDERWATER STRUCTURE COATED WITH THESE COATING FILMS | CHUGOKU MARINE PAINTS, LTD. (JP) | 2009-09-10 | — | — | US | claimed |
| US-20080234380-A1 | Compositions and method for treatment of chronic inflammatory diseases | SHAPIRO HOWARD K | 2008-09-25 | — | — | US | claimed |
| EP-1788048-A1 | HIGH-SOLID ANTICORROSIVE COATING COMPOSITION, HIGH-SOLID RAPIDLY-CURABLE ANTICORROSIVE COATING COMPOSITION, METHOD OF COATING SHIP OR THE LIKE, HIGH-SOLID ANTICORROSIVE FILM AND RAPIDLY CURED HIGH-SOLID ANTICORROSIVE FILM OBTAINED, AND COATED SHIP AND UNDERWATER STRUCTURE COATED WITH THESE COATING FILMS | CHUGOKU MARINE PAINTS, LTD. (JP) | 2007-05-23 | — | — | EP | claimed |
| US-20050090553-A1 | Compositions and method for treatment of chronic inflammatory diseases | SECANT PHARMA, LLC | 2005-04-28 | — | — | US | claimed |
| US-6808933-B1 | Methods of enhancing confidence in assays for analytes | AGILENT TECHNOLOGIES, INC. | 2004-10-26 | — | — | US | claimed |
| EP-0367484-B1 | Carboxylic acid derivates | GLAXO GROUP LTD (GB) | 1994-02-16 | — | — | EP | claimed |
| US-5273984-A | Bismuth complex having a carboxylic acid to form a salt of the basic antagonist excluding ranitidine | GLAXO GROUP LIMITED (GB) | 1993-12-28 | — | — | US | claimed |
| WO-1993021276-A1 | MISCIBLE THERMOPLASTIC COMPOSITIONS CONTAINING POLYAMIDE/AMORPHOUS POLYAMIDE BLENDS | ALLIED-SIGNAL INC. (US) | 1993-10-28 | — | — | WO | claimed |
| EP-0275669-B1 | USE OF HETEROCYCLIC DERIVATIVES FOR THE MANUFACTURE OF MEDICAMENTS | GLAXO GROUP LIMITED (GB) | 1992-09-30 | — | — | EP | claimed |
| EP-0454449-A1 | Carboxylic acid derivatives | GLAXO GROUP LIMITED (GB) | 1991-10-30 | — | — | EP | claimed |
| EP-0367484-A1 | Carboxylic acid derivates | GLAXO GROUP LIMITED (GB) | 1990-05-09 | — | — | EP | claimed |
| EP-0275669-A1 | Use of heterocyclic derivatives for the manufacture of medicaments | GLAXO GROUP LIMITED (GB) | 1988-07-27 | — | — | EP | claimed |
| EP-0023578-B1 | AMINOALKYLBENZENE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS | SHIONOGI & CO., LTD. (JP) | 1984-05-30 | — | — | EP | claimed |
| EP-0023578-A1 | Aminoalkylbenzene derivatives, process for their preparation and pharmaceutical compositions | SHIONOGI & CO., LTD. (JP) | 1981-02-11 | — | — | EP | claimed |
| US-4220450-A | Chemically induced fluorescence immunoassay | SYVA COMPANY (US) | 1980-09-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090553-A1 | Compositions and method for treatment of chronic inflammatory diseases | PCCA, HMGB1, PTGES | MAOB 276/4885CA1 1403/4885CA2 1000/4885 |
| US-20080234380-A1 | Compositions and method for treatment of chronic inflammatory diseases | HMGB1, PCCA, QSOX1 | MAOB 262/4885CA1 1105/4885CA2 1023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.